Absolute Return Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Absolute Return Capital’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,846	Closed	-$919K	–	47
2015 Q3	$919K	Sell	6,846 -18,672	-73%	-$2.69M	0.06%	294
2015 Q2	$3.84M	Sell	25,518 -7,560	-23%	-$1.08M	0.15%	180
2015 Q1	$4.47M	Buy	33,078 +31,060	+1,539%	+$3.85M	0.12%	198
2014 Q4	$243K	Sell	2,018 -17,431	-90%	-$2.01M	0.01%	579
2014 Q3	$2.21M	Sell	19,449 -2,276	-10%	-$270K	0.03%	436
2014 Q2	$2.6M	Buy	21,725 +12,058	+125%	+$1.47M	0.03%	530
2014 Q1	$1.24M	Sell	9,667 -7,006	-42%	-$898K	0.02%	592
2013 Q4	$2.06M	Sell	16,673 -17,993	-52%	-$2.19M	0.02%	510
2013 Q3	$4.08M	Buy	34,666 +12,709	+58%	+$1.5M	0.06%	371
2013 Q2	$2.46M	Buy	+21,957	New	+$2.58M	0.03%	498

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Absolute Return Capital's BIO Position: Q4 2015 in Review

Absolute Return Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2015, closing a stake of 6,846 shares — an estimated $919K sold.

Absolute Return Capital first reported a position in BIO in Q2 2013 and held it in 10 quarters. The position peaked at $4.47M in Q1 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q4 2015.

Absolute Return Capital reported no remaining Bio-Rad Laboratories Class A position as of Q4 2015 after selling out during the quarter.
Absolute Return Capital sold 6,846 Bio-Rad Laboratories Class A shares in Q4 2015, an estimated $919K.
Absolute Return Capital first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 10 quarters.
Absolute Return Capital's Bio-Rad Laboratories Class A position peaked at $4.47M in Q1 2015.
241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.